前列腺癌
癌症
恶性肿瘤
医学
癌症治疗
前列腺
内科学
作者
Ruimin Hu,Lan Jin,Dinglin Zhang,Wenhao Shen
出处
期刊:Biomaterials
[Elsevier]
日期:2024-03-01
卷期号:305: 122469-122469
被引量:1
标识
DOI:10.1016/j.biomaterials.2024.122469
摘要
Prostate cancer (PCa) is the most prevalent solid organ malignancy and seriously affects male health. The adverse effects of prostate cancer therapeutics can cause secondary damage to patients. Nanotherapeutics, which have special targeting abilities and controlled therapeutic release profiles, may serve as alternative agents for PCa treatment. At present, many nanotherapeutics have been developed to treat PCa and have shown better treatment effects in animals than traditional therapeutics. Although PCa nanotherapeutics are highly attractive, few successful cases have been reported in clinical practice. To help researchers design valuable nanotherapeutics for PCa treatment and avoid useless efforts, herein, we first reviewed the strategies and challenges involved in prostate cancer treatment. Subsequently, we presented a comprehensive review of nanotherapeutics for PCa treatment, including their targeting methods, controlled release strategies, therapeutic approaches and mechanisms. Finally, we proposed the future prospects of nanotherapeutics for PCa treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI